Herpes Zoster Ophthalmicus
| Autor: | Rianot Amzat, Nicolle Martin, Julie L. Johnson |
|---|---|
| Rok vydání: | 2015 |
| Předmět: |
medicine.medical_specialty
Pediatrics Herpes Zoster Vaccine Population Antiviral Agents Diagnosis Differential Adrenal Cortex Hormones Risk Factors medicine Humans Pain Management Pharmacology (medical) Infectious disease (athletes) education Referral and Consultation education.field_of_study Primary Health Care business.industry Incidence Incidence (epidemiology) medicine.disease United States Surgery Self Care Vaccination Ophthalmic zoster Herpes Zoster Ophthalmicus Quality of Life business Shingles |
| Zdroj: | Primary Care: Clinics in Office Practice. 42:285-303 |
| ISSN: | 0095-4543 |
| DOI: | 10.1016/j.pop.2015.05.007 |
| Popis: | Herpes zoster is a commonly encountered disorder. It is estimated that there are approximately 1 million new cases of herpes zoster in the United States annually, with an incidence of 3.2 per 1000 person-years. Patients with HIV have the greatest risk of developing herpes zoster ophthalmicus compared with the general population. Other risk factors include advancing age, use of immunosuppressive medications, and primary infection in infancy or in utero. Vaccination against the virus is a primary prevention modality. Primary treatments include antivirals, analgesics, and anticonvulsants. Management may require surgical intervention and comanagement with pain specialists, psychiatrists, and infectious disease specialists. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|